Ascidian Therapeutics
Clinical-stage biotechnology company developing RNA editing therapeutics for inherited retinal diseases and other genetic conditions, using proprietary ADAR-mediated RNA editing technology.
Website
https://www.ascidiantx.comLocation
Boston, Massachusetts, USA
Founded
2020
Investors
1
Categories
biotech, RNA-editing, ophthalmology, gene-therapy, rare-disease
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| Apple Tree Partners | New York, USA | biotech-focused | series-aseries-b+2 | 23 |
